Genmab Market Cap

Genmab has a market cap or net worth of €15.18 billion as of September 26, 2025. Its market cap has decreased by -3.73% in one year.

Market Cap

15.18B

Enterprise Value

12.84B

Revenue

3.11B

Ranking

n/a

PE Ratio

13.01

Stock Price

€245.60

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 485.53M to 15.18B, an increase of 3,027.24%. That is a compound annual growth rate of 14.79%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	15.18B	19.40%
Dec 30, 2024	12.72B	-32.67%
Dec 29, 2023	18.89B	-26.92%
Dec 30, 2022	25.84B	11.67%
Dec 30, 2021	23.14B	6.90%
Dec 30, 2020	21.65B	67.74%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	262.21B
Siemens Aktiengesellschaft	177.42B
Deutsche Telekom AG	136.77B
Allianz SE	136.28B
Rheinmetall AG	89.95B
Siemens Energy AG	84.11B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	69.76B
Deutsche Bank Aktiengesellschaft	58.48B

Market Cap Rankings